R Pazdur|M K Samson|L H Baker - JoVE Visualize

Showing results (11-20 of 250) with videos related to

Pageof 25

Sort By:

American Journal of Clinical Oncology|April 1, 1985

Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trialM K Samson, C D Haas, L H Baker, et al.

Cancer Treatment Reports|September 1, 1976

Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanomaM K Samson, L H Baker, R M Izbicki, et al.

Cancer Research|August 1, 1987

Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.

Cancer Treatment Reports|November 1, 1979

Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lungR J Fraile, M K Samson, L H Baker, et al.

American Journal of Clinical Oncology|August 1, 1984

Phase II clinical evaluation of AZQ in adenocarcinoma of the lungD A Decker, M K Samson, C D Haas, et al.

Cancer|November 1, 1976

Alterations in plasma sialyltransferase associated with successful chemotherapy of a disseminated tumor. Case reportD Kessel, M K Samson, P Shah, et al.

Cancer Clinical Trials|January 1, 1979

Use of VM-26 as a single agent in the treatment of renal carcinomaE A Hire, M K Samson, R J Fraile, et al.

Cancer Treatment Reports|December 1, 1987

Phase I study of echinomycinR Pazdur, C D Haas, L H Baker, et al.

Cancer Chemotherapy Reports|November 1, 1975

Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.

Cancer Treatment Reports|November 1, 1979

Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group StudyM K Samson, L H Baker, R S Benjamin, et al.

Pageof 25

Showing results (11-20 of 250) with videos related to

Sort By:

Pageof 25

American Journal of Clinical Oncology|April 1, 1985

Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trialM K Samson, C D Haas, L H Baker, et al.

Cancer Treatment Reports|September 1, 1976

Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanomaM K Samson, L H Baker, R M Izbicki, et al.

Cancer Research|August 1, 1987

Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.

Cancer Treatment Reports|November 1, 1979

Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lungR J Fraile, M K Samson, L H Baker, et al.

American Journal of Clinical Oncology|August 1, 1984

Phase II clinical evaluation of AZQ in adenocarcinoma of the lungD A Decker, M K Samson, C D Haas, et al.

Cancer|November 1, 1976

Alterations in plasma sialyltransferase associated with successful chemotherapy of a disseminated tumor. Case reportD Kessel, M K Samson, P Shah, et al.

Cancer Clinical Trials|January 1, 1979

Use of VM-26 as a single agent in the treatment of renal carcinomaE A Hire, M K Samson, R J Fraile, et al.

Cancer Treatment Reports|December 1, 1987

Phase I study of echinomycinR Pazdur, C D Haas, L H Baker, et al.

Cancer Chemotherapy Reports|November 1, 1975

Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.

Cancer Treatment Reports|November 1, 1979

Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group StudyM K Samson, L H Baker, R S Benjamin, et al.

Pageof 25